Engage Therapeutics Announces Data from Phase 2a, Proof-of-concept Study of Staccato Alprazolam to Suppress Seizures in Patients with Epilepsy Published in Epilepsia

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy